CAR-T Therapy for Non-Hodgkin Lymphomas (DLBCL, FL, MCL) at Sheba Medical Center
What's included in this package
Medical Procedures
- CAR T-cell therapy
- 3 meals per day by nutritionist
- 24-hr nurse services
- CT Scan
- Electrocardiogram (ECG)
- Consultation with a doctor
- Blood tests
- Follow-up examination
- Ultrasound
- Echocardiography
- Biochemistry blood test
- PET/CT
- Consultation with an oncologist
- Consultation with a hematologist
- Follow-up visit
- Consultation with an immunologist
- Consultation with a neurologist
- Consultation with a cardiologist
- Consultation with a pediatric hematologist
- Сonsultation with an oncohematologist
- Complete blood count with cancer markers and a proteinogram
- CT angiography
Duration
- 21 days in the hospital
- 7 days in the hotel
Accommodation
Hospitalization
Transport
Transfer airport-clinic-airport
Additional information
CAR-T Therapy for Non-Hodgkin Lymphomas (DLBCL, FL, MCL) at Sheba Medical Center
For patients facing relapsed or resistant Non-Hodgkin lymphoma, finding the right treatment center can make a life-changing difference.
Sheba Medical Center, one of the world’s leading hospitals, offers advanced CAR-T cell therapy, providing new hope when standard treatments are no longer effective.
Sheba specializes in treating DLBCL, Follicular Lymphoma (FL), and Mantle Cell Lymphoma (MCL) with a highly personalized approach, combining cutting-edge science, speed, and clinical expertise.
A Faster Path to Treatment When Time Matters Most
At Sheba, the entire CAR-T process is performed on-site, without delays caused by external laboratories.
• T-cells are collected (apheresis)
• Genetically engineered at Sheba’s Advanced Biotherapy Center
• Reinfused to target and destroy lymphoma cells
This streamlined approach allows treatment to begin in approximately 10 days, significantly faster than many international centers.
CAR-T therapy acts as a “living drug”, continuing to work inside the body and offering the potential for long-term remission.
All patients are treated under the leadership of Prof. Arnon Nagler, a world-renowned expert in hemato-oncology.
Proven Results That Offer Real Hope
Even in complex and advanced cases, CAR-T therapy at Sheba has demonstrated high remission rates
• Up to 90% in pediatric patients
These outcomes provide a meaningful second chance for patients who have exhausted other options.
Why Patients Choose Sheba
• Rapid access to treatment – no waiting weeks for cell production
• Extensive experience – one of the largest CAR-T programs in the region
• Dedicated CAR-T units – with 24/7 expert monitoring
• Multidisciplinary care – leading specialists working together on every case
• Full international support – from medical review to travel and coordination
Comprehensive, Personalized Care
Each patient undergoes a complete evaluation, including advanced imaging, genetic and molecular testing, and full medical assessment, ensuring the most effective, tailored treatment plan.
Services are available in English, Russian, and Arabic, making the experience smooth and supportive for international patients.
A Global Leader in Advanced Cancer Care
By combining speed, innovation, and world-class expertise, Sheba delivers one of the most advanced and accessible CAR-T programs for lymphoma patients worldwide, offering not just treatment, but a real opportunity for remission and renewed quality of life.
24/7 Bookimed assistance
- Personal medical coordinator
- Medical travel arrangements — booking of air tickets and hotel rooms at special partner prices
- Patient advocacy during medical travel
Program price
special price valid till August 27, 2026
What's NOT included in this package
Doctor
Dr. Arnon Nagler is a hematologist at Sheba Medical Center in Israel. He is a professor at Tel Aviv University and a renowned transplant expert. Dr. Nagler founded Israel’s first public cord blood bank. He also performed the first cord blood transplantations in the country. He completed postdoctoral training at Stanford University and is board-certified in hematology.
- Pioneered reduced–intensity allogeneic transplant protocols for blood cancers.
- Served as Chair of the Acute Leukemia Working Party for the EBMT.
- Published over 400 articles in leading journals like Blood and Leukemia.
- Works at Sheba Medical Center, ranked 7th worldwide by Newsweek in 2026.
How are we doing?
About the clinic
Sheba Medical Center is the largest hospital in the Middle East and ranked 7th worldwide by Newsweek in 2026. It treats over 2 million patients annually and is a global leader in CAR-T and TIL immunotherapies. Core specialties include oncology, immunotherapy, precision medicine, and cardiology.
- JCI and ISO accredited with eight consecutive years in the Newsweek global Top 10.
- In-house CAR-T manufacturing through its GMP-certified Advanced Biotherapy Center (ABC).
- Over 200 Sheba doctors are listed among Forbes' Top Doctors.
- One of the few centers worldwide developing CAR-T therapies for severe autoimmune diseases.
- Campus includes six major hospitals, among them the Leviev Heart Center and Edmond and Lily Safra Children's Hospital.
Payment & Rewards
You don’t pay for our services
You make your payment directly at the clinic or to their official bank account.
Some clinics may require a deposit as a part of their policy.
Spread out your payments with installment options.
Earn rewards for referring friends to Bookimed.